2019 International Congress Archives - Page 130 of 217

Camillo Negro and his contributions to Neurology

A. Meira, B. Betini, F. Germiniani, H. Teive (Curitiba, Brazil)
Camptocormia in Parkinson’s disease – impaired kinesthesia of the trunk extensors

R. Wolke, J. Kuhtz-Buschbeck, G. Deuschl, N. Margraf (Kiel, Germany)
Can a smartphone accelerometer differentiate between functional and organic tremor ?

M. Khider Ahmed, T. Mouton, J. Ackerman, N. Brey, C. Albertyn, F. Henning, J. Carr (Cape Town, South Africa)
Can Google Glass improve freezing of gait in parkinsonism? A pilot study

A. Lee, N. Hellmers, M. Vo, P. Popa, C. Henchcliffe, H. Sarva, C. Campbell (New York, NY, USA)
Can people with Parkinson’s disease rely on their coping capacity over time? A longitudinal study using the Sense of Coherence (SOC) scale

J. Andersson, G-M. Hariz, L. Forsgren (Umeå, Sweden)
Can Safinamide Help to Stabilize Dopaminergic Treatment in Parkinson’s Disease?

B. Solano Vila, A. Cots Foraster, M. Montserrat Roses (Girona, Spain)
Can the Quantified Timed Up and Go (QTUG) device support decision making for patients undergoing Deep Brain Stimulation?

J. Somerset, B. Hammersley, M. Bonello (Liverpool, United Kingdom)
Can we hear pathology in premanifest Huntington’s disease? Acoustic and listener-based analysis of speech

J. Chan, C. Shirbin, J. Stout, A. Vogel (Melbourne, Australia)
Cardiac involvement in AVED

S. Lucas-Delpozo, D. Moreno-Martínez, M. Tejero-Ambrosio, J. Hernández-Vara (Barcelona, Spain)
Cardiovascular autonomic function and MCI in Parkinson’s disease

CE. Cicero, L. Raciti, R. Monastero, G. Mostile, G. Donzuso, G. Sciacca, A. Luca, C. Terravecchia, L. Giuliano, R. Baschi, M. Davì, M. Zappia, A. Nicoletti (Catania, Italy)
Caregiver burden does not improve in the long-term after deep brain stimulation for Parkinson disease

E. Jackowiak, A. Maher, C. Persad, P. Patil, K. Chou (Ann Arbor, MI, USA)
Caregiver support and its association with advanced Parkinson’s disease and clinical outcomes

A. Fasano, L. Bergmann, V. Fung, Y. Jalundhwala, K. Onuk, Z. Pirtosek, W. Robieson, K. Seppi, A. Takáts, P. Martinez-Martin (Totronto, ON, Canada)
Carotid Intima-Media Thickness and its correlates in people with Parkinson’s disease: a pilot study

S. Castillo-Torres, C. Soto-Rincón, D. Cantú-García, A. Mendoza-Garcia, D. Díaz-Pérez, D. Martínez-Roque, B. Chávez-Luévanos, I. Estrada-Bellmann, F. Góngora-Rivera (Monterrey, Mexico)
Carpal Tunnel Syndrome in Patients with Tremor

L. Jackson, F. Ali (Rochester, MN, USA)
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

M. Bhargava, S. Bhargava (Kanpur, India)
Case of task-specific tremor and task-specific dystonia with contralateral spread

L. Jackson, F. Ali (Rochester, MN, USA)
Case report: Chorea-acynthocytosis with two compoud heterozygous VPS13A large deletions

D. Spieler, A. Mühlbäck, A. Velayos-Baeza, F. Castrop, C. Maegerlein, J. Slotta-Hispenina, B. Bader, B. Haslinger, J. Klempir, A. Danek (Freiburg, Germany)
Case Report: Co-occurrence of Motor Neuron Disease and Parkinsonism

B. Barton (Chicago, IL, USA)
Case Series of 3 Individuals of African Descent with Dentatorubral-Pallidoluysian Atrophy

C. Kutz, C. Bundukamara (Colorado Springs, CO, USA)
Case-control study of risk developing parkinsonism in Alzheimer’s disease in relation to hypertension, dyslipidemia, and diabetes in Taiwan

W. Lin, PY. Chiu (Changhua, Taiwan)
Caudal posterior substantia nigra iron increases longitudinally in Parkinson’s disease

N. Bergsland, R. Zivadinov, F. Schweser, J. Hagemeier, D. Lichter, T. Guttuso, JR. (Buffalo, NY, USA)
Central cholinergic activity and risk of falls in patients with Parkinson’s disease and freezing of gait

E. Pelosin, G. Lagravinese, G. Bonassi, M. Putzolu, A. Mirelman, R. Marchese, L. Avanzino (Genova, Italy)
Central effects of botulinum neurotoxin injections in cervical dystonia – a longitudinal structural MRI-study

D. Weise, C. Awissus, P. Baum, J. Classen, A. Villringer, P. Ragert, C. Weise (Leipzig, Germany)
Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease

M. Tagliati, E. Hogg, T. Wu, K. Makwana, H. Maghzi, A. Garland, E. Tan, C. Riera (Los Angeles, CA, USA)
Cerebellar ataxia and cutaneous lesions: a clinical case

L. Azevedo Kauppila, P. Dias, C. Silva, A. Sousa, M. Rosa, L. Correia Guedes (Lisboa, Portugal)
Cerebellar Ataxia in Patients with Huntington’s Disease, an underestimated symptom?

GLF. Franklin, HAT. Teive, FBG. Germiniani, SR. Raskin, GMP. Pavanelli, SSM. Milano, NSL. Lima, OPB. Barsottini, JLP. Pedroso, FAM. Maggi, VT. Tumas, PMC. Carvalho, PCA. Azevedo, ILC. Lopes-Cendes (Curitiba, Brazil)
Cerebellar brain inhibition and cervical dystonia: exploring clinico-electrophysiological associations

R. Sondergaard, LS. Gan, Y. Jasaui, J. Sarna, S. Furtado, T. Pringsheim, D. Martino (Calgary, AB, Canada)
Cerebellar involvement in progressive supranuclear palsy and corticobasal degeneration

S. Jo, KW. Park, N. Choi, CS. Lee, MS. Kim (Seoul, Republic of Korea)
Cerebellar rTMS theta burst for postural instability in progressive supranuclear palsy: a double blind cross-over sham controlled study using wearing sensors technology

A. Pilotto, MC. Rizzetti, A. Lombardi, M. Biggi, G. Verzeroli, W. Maetzler, C. Hansen, B. Borroni, A. Padovani (Brescia, Italy)
Cerebellar Structural changes in Patients with Parkinson’s disease and Essential Tremor

A. Lopez, P. Trujillo, B. Landman, P. Hedera, D. Claassen (Nashville, TN, USA)
Cerebellar transcranial magnetic stimulation with neuronavigation for postural instability in PSP

M. George, W. Devries, M. Dale (Charleston, SC, USA)
Cerebral cavernous malformations and movement disorders

M. Polemikos, E. Hermann, J. Krauss (Hannover, Germany)
Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson’s tremor

MF. Dirkx, H. Zach, A. van Nuland, BR. Bloem, I. Toni, RC. Helmich (Nijmegen, Netherlands)
Cerebral palsy masqueraders in an adult movement disorder tertiary centre: when to investigate an alternative diagnosis?

S. Duarte, R. Martins, M. Magalhães (Porto, Portugal)
Cerebrotendinous Xanthomatosis presenting Parkinsonism with bilateral iron accumulation in the basal ganglia

J. Li, S. Liu, E. Xu, H. Qiao, W. Mao, P. Chan (Beijing, China)
Certification of cause of death in patients with Parkinson’s Disease (PD)

M. Khwaja, A. Chatterjee (Reading, United Kingdom)
Cervical and Lumbosacral Spondylosis is common in patients with Parkinsonism in rural Western India

S. Desai (Anand, India)
Challenges in Parkinson’s Disease Diagnosis in a Patient with Ipsilateral Hemimelia

G. Fabiani, FMB. Germiniani, HA. Teive (Curitiba, Brazil)
Change of extracellular glutamate and GABA level in striatum during deep brain stimulation of the entopeduncular nucleus in rats

CB. Cho, JH. Sung (Suwon, Republic of Korea)
Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)
Changes in GABAergic transmission of striatal neurons in presymptomatic Huntington’s Disease

M. Treven, F. Zirpel, I. Mody (Vienna, Austria)
Changes in Neuromelanin MRI Signal in Parkinson’s Disease: A Longitudinal Study

R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabregue, C. Ewenczyk, M. Hutchison, J. Corvol, M. Vidailhet, S. Lehéricy (Paris, France)
Changes in Supine Blood Pressure with Long Term Use of Droxidopa

S. Gorny, L. Hewitt, A. Lindsten, M. Karnik-Henry, S. Kymes, A. Favit (Deerfield, IL, USA)
Changes of cutaneous and cortical silent responses in a random sample of Lithuania patients with Parkinson disease

L. Sinkunaite, J. Svilpauske-Lauryniene, D. Garsviene, D. Surkiene (Kaunas, Lithuania)
Changes to Speech Production after SpeechVive Treatment in Individuals with Parkinson’s Disease

J. Huber, E. Stathopoulos, J. Sussman, K. Richardson, D. Matheron, S. Snyder (West Lafayette, IN, USA)
Changing for a rechargeable neurostimulator in Parkinson’s disease patients: safety and feasibility

T. Wirth, C. Laurencin, J. Berthiller, A. Brindzeu, E. Simon, G. Polo, P. Mertens, E. Broussolle, T. Danaila, S. Thobois (Strasbourg, France)
Characterising the role of alpha-synuclein in ferroptotic programmed cell death in the context of Parkinson’s Disease

L. Mahoney-Sánchez, H. Bouchaoui, K. Timmerman, A. Jonneaux, S. Ayton, J. Duce, JC. Devedjian, D. Devos (Lille, France)
Characteristic Parkinsonism Questionnaire for the Discrimination of Parkinson’s Disease Dementia from Vascular Dementia

PY. Chiu (Changhua, Taiwan)
Characteristics and correlative factors of autonomic dysfunction in Chinese Parkinson’s disease

Z. Zhou, LP. Zhu, XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Y. Yang, LJ. Fang, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)
Characteristics and outcome of patients with Parkinson’s disease admitted to intensive care unit

O. Benhadj Salem, S. Demeret, A. Demoule, F. Bolgert, H. Outin, T. Sharshar, D. Grabli (Paris, France)
Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice

M. Dean, M. Patel, K. Barnes, D. Standaert (Birmingham, AL, USA)
Characteristics of arm tremors in primary orthostatic tremor

J. Tashiro, H. Ohtsuka, M. Hirotani, Y. Iida, S. Hamada, H. Soma, M. Nonaka, S. Honma, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)
Characteristics of gait and quality of life in Parkinson’s disease

JW. Kim, SM. Cheon (Busan, Republic of Korea)
Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)
Characteristics of patients with essential tremor evaluated for deep brain stimulation surgery at a tertiary center

L. Deuel, J. Feuerstein, B. Berman, B. Hoyt, D. Kern (Aurora, CO, USA)
Characteristics of spontaneous brain activity in left- and right-onset Parkinson’s disease patients

K. Li, W. Su, H. Zhao, C. Li, X. Ma, B. Lou, M. Chen, H. Chen (Beijing, China)
Characteristics of the clinical and cerebral metabolism in Parkinson’s disease with atrophy in nucleus basalis of Meynert

MY. Gang, T. Baba, Y. Hosokai, Y. Nishio, A. Kikuchi, K. Hirayama, T. Hasegawa, M. Aoki, A. Takeda, E. Mori, K. Suzuki (Sendai, Japan)
Characterization of cerebrospinal fluid profile in hereditary spastic paraparesis 10

M. Andréasson, K. Lagerstedt-Robinson, K. Samuelsson, G. Solders, K. Blennow, M. Paucar, P. Svenningsson (Stockholm, Sweden)
Characterization of impulsivity in Colombian patients with Huntington’s disease

L. Colmenares, C. Rodriguez, W. Fernandez (Bogotá, Colombia)
Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease

X. Chai, S. Diwakarla, R. Pustovit, R. Mcquade, M. Di Natale, C. Ermine, C. Parish, D. Finkelstein, J. Furness (Melbourne, Australia)
Characterization of the motor phenotype and striatal muscle analysis in a mouse model of hereditary spasticity

A. Vignaud, C. Rivares, W. Noort, B. Koopmans, M. Loos, RT. Jaspers, M. Kalinichev (Les Ulis, France)
Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)
CHCHD2 maintains the MICOS and inhibits PINK1/Parkin mediated mitophagy in an experimental model of Parkinson’s disease

X. Chen, M. Zhou, XQ. Zhu, SX. Huang, WY. Guo, Z. Pei, PY. Xu (Guangzhou, China)
Chlorogenic acid and Trianthema portulacastrum combinational therapy mitigates rotenone induced Parkinsonism in wistar rats

E. Yadav (Prayagraj, India)
Chlorogenic acid attenuates the MPTP induced apoptosis in Parkinson’s disease mouse model through pAkt signaling pathway

S. Singh, S. Singh (Varanasi, India)
Cholecalciferol (VD3) attenuated motor deficits and dyskinesia in Hemi-Parkinsonian mice: behavioural, biochemical & electrophysiological implications

A. Bayo-Olugbami, A. Oyewole, A. Nafiu, A. Amin, B. Ogundele, B. Owoyele, C. Lee (Ilorin, Nigeria)
Chorea-acanthocytosis: Challenges in early diagnosis and excellent treatment response to Deep Brain Stimulation (DBS) – a case report

J. Walch, F. Brugger, D. Brogle, R. Bauer, S. Haegele-Link, G. Kägi (St. Gallen, Switzerland)
Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

K. Fifel, T. Deboer (Leiden, Netherlands)
Circumstances of Falls in Single and Recurrent Fallers with Parkinson’s Disease

I. Castro, H. Cavalcanti, G. Valença, J. Filho, L. Almeida (Salvador, Brazil)
Classification of idiopathic cervical dystonia: an observational study

P. Tater, N. Sarma, S. Pandey (New Delhi, India)
Classification of Neurorehabilitation treatments: Preliminary results of a Multicentre Italian Study

T. Bowman, F. Mestanza Mattos, R. Russo, M. Boninsegna, F. Marazzini, A. Marianelli, E. Pelosin, M. Putzolu, C. Cosentino, M. Petrarca, F. Tirinelli, M. Tondinelli, F. Trecate, M. Budel, A. Turolla, M. Agostini, D. Munari, P. Pillastrini, M. Branchini, D. Lunedei, G. Sgubin, D. Cattaneo, S. Mezzarobba (Milano, Italy)
Classification of spinocerebellar degeneration based on ratio of brainstem white matter to cerebellar gray matter by voxel-based morphometry

T. Taguchi, K. Nanri, H. Kato, H. Terashi, H. Aizawa (Tokyo, Japan)
Classify Parkinson’s Disease with Mild Cognitive Impairment: Machine Learning Approach

SS. Cho, C. Li, Y. Koshimori, J. Kim, L. Christopher, M. Dı´ez-Cirarda, M. Valli, A. Mihaescu, S. Houle, A. Strafella (Toronto, ON, Canada)
Clear versus conversational speech in Parkinson’s disease, progressive supranuclear palsy, and multiple system atrophy

T. Tykalova, D. Skrabal, J. Klempir, E. Ruzicka, J. Rusz (Prague, Czech Republic)
Clinical and cognitive features of anxiety in Parkinson’s disease

G. Carey, L. Defebvre, A. Moonen, A. Leentjens, K. Dujardin (Lille, France)
Clinical and DAT Imaging Characteristics of Participants with Scans without Evidence of Dopaminergic Deficit (SWEDDs): PPMI Cohort 2 year follow-up

K. Marek, T. Simuni, A. Siderowf, D. Lafontant, C. Caspell-Garcia, C. Coffey, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, J. Seibyl (New Haven, CT, USA)
Clinical and epidemiological data on Parkinson’s disease in older adults: experience of a single Italian centre.

T. Schirinzi, G. Di Lazzaro, M. Pierantozzi, A. Stefani, N. Mercuri, A. Pisani (Rome, Italy)
Clinical and fMRI effects of Action Observation and Motor Imagery Training on dual-task performances in Parkinson’s disease patients with postural instability and gait disorders

E. Sarasso, F. Agosta, N. Piramide, E. Canu, M. Chiesi, I. Ravani, S. Galantucci, A. Tettamanti, MA. Volontè, M. Filippi (Milan, Italy)
Clinical and genetic characteristics of a new mutation causing Segawa´s disease in a Spanish kindred

J. Hernández-Vara, S. Lucas (Barcelona, Spain)
Clinical and genetic features of paroxysmal kinesigenic dyskinesia (PKD) studied with whole exome sequencing (WES)

Z. Xu, Z. Lu, CK. Lim, SC. Low, E. Ng, AH. Tan, SY. Lim, EK. Tan, LCS. Tan (Singapore, Singapore)
Clinical and genetic heterogeneity in Indian subcontinent patients with Autosomal Dominant Spinocerebellar Ataxia 42

A. Mehta, M. Javali, P. R, K. Haskar, D. Gupta, P. Acharya, S. Srinivasa (Bengaluru, India)
Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort

A. Siderowf, T. Simuni, M. Brumm, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Chicago, IL, USA)
Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort

A. Siderowf, T. Simuni, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollehauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Philadelphia, PA, USA)
Clinical and molecular features of a Chinese family with spinocerebellar ataxia type 6

H. Luan, A. Liu (Yantai, China)
Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)
Clinical Applications of Non-Invasive Neuromodulation associated with kinesiotherapy in focal dystonia patients: report of three cases

C. Souza, J. Goulardins, D. Boari, S. Casagrande, J. Papaterra, C. Boffino, C. Tanaka, K. Monte-Silva (Sao Paulo, Brazil)
Clinical Associations of Hand Deformities in Parkinson´s Disease

JF. Baizabal-Carvallo, M. Alonso-Juarez, R. Fekete (Valhala, NY, USA)
Clinical Audit of Hospital Admissions for Parkinson Disease

HL. Lan, LW. Wei, ST. Shu Ting, KY. Kay Yaw, WL. Wing Lok, LT. Louis Cs (Singapore, Singapore)
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE

A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)
Clinical comparison of right onset PD vs left onset PD

B. Tserensodnom (Ulaanbaatar, Mongolia)
Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study

H. Soares, Z. Jin, N. Fisseha, M. Gold, C. Locke, B. Rendenbach-Mueller, E. Smith, I. Suridjan, A. Vasanthakumar, N. Mendonca (Ludwigshafen, Germany)
Clinical correlation between 99mTc-TRODAT-1 SPECT and parkinsonism

AC. Chen (Taichung, Taiwan)
Clinical features of constipation in patients with Parkinson’s disease: a cross-sectional study in China

LP. Zhu, XT. Zhou, Z. Zhou, LJ. Fang, XX. Zhou, YW. Zhao, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)
Clinical heterogeneity and neuropathological correlation in progressive supranuclear palsy – description of 4 cases

A. André, M. Malaquias, C. Pinto, M. Calejo, A. Correia, M. Pires, P. Pinto, A. Mendes, M. Magalhães, R. Taipa (Faro, Portugal)
Clinical hypnosis in functional movement disorders: a potential therapeutic strategy

C. Buiza-Aguado, C. Ordas-Bandera, M. Guillan-Rodriguez, J. Del Val, PJ. Garcia Ruiz-Espiga, JC. Martinez-Castrillo, I. Parees-Moreno, A. Alonso-Canovas (Madrid, Spain)
Clinical Management of Incipient Wearing-off with the 19-Items Wearing off Questionnaire (WOQ-19)

V. Puente Périz, I. Navalpotro Gómez, A. Crespo Cuevas, A. Puig Pijuan, A. Fernandez Lebrero, D. Lahoz (Barcelona, Spain)
Clinical outcome in early-treated Sepiapterine Reductase Deficiency (SRD): A case report

F. Nardecchia, S. Galosi, F. Manti, MT. Giannini, C. Carducci, M. Tolve, V. Leuzzi (Rome, Italy)
Clinical patterns of gait freezing in Parkinson’s disease and their response to interventions: an observer-blinded study

O. Gavriliuc, S. Paschen, A. Andrusca, C. Schlenstedt, G. Deuschl (Chisinau, Republic of Moldova)
Clinical Profile and Response to EMG-Guided Botulinum toxin (BTX) Injection in Writers’ Cramp (WC)- A Study of 25 Indian Patients

P. Agarwal, P. Palekar (Mumbai, India)
Clinical profile and treatment response patterns in patients of Truncal Dystonia: A retrospective case series from a tertiary care hospital in India

S. Mehta, S. Ray, V. Lal (Chandigarh, India)
Clinical profile of idiopathic Parkinson’s disease in patients admitted to Mohamed VI University Hospital center of Marrakech

A. Boudanga, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)
Clinical Response to 72-h Lumbar CSF Drainage in Idiopathic Normal Pressure Hydrocephalus associated with Parkinsonism: Timing and Correlates

G. Mostile, G. Raudino, G. Portaro, F. Certo, A. Nicoletti, G. Barbagallo, M. Zappia (Catania, Italy)
Clinical Results in Argentines Patients with STN DBS in Parkinson’s Disease

C. Ramirez Gomez, N. Portinari, J. Travi, V. Montilla Uzcategui, F. Micheli, F. Piedimonte (Buenos Aires, Argentina)
Clinical spectrum of Functional Movement Disorders: A clinic based study from a developing country

D. Dash, M. Tripathi, R. Singh (Delhi, India)
Clinical-instrumental algorithm for assessment visuospatial dysfunction in patients with Parkinson’s disease

K. Stepanchenko (Kharkiv, Ukraine)
Clinical, genetic and radiological characterization of patients with movement disorders and basal ganglia calcification

F. Arienti, G. Franco, E. Monfrini, A. Seresini, A. Di Fonzo (Milan, Italy)
Clinical, motor and global cognition in patients with in early stages of Parkinson disease

J. Orozco, J. Valderrama, Y. Castaño, J. Arango, A. Navarro, B. Muñoz (Cali, Colombia)
Clinically Relevant Changes in AIMS Based on Clinical and Patient Global Impression of Change in Patients With Tardive Dyskinesia Treated with Deutetrabenazine

H. Barkay, A. Wilhelm, M. Wieman, M. Gordon, R. Hauser, JM. Savola (Netanya, Israel)
Clinico-genetic correlation in 102 Spinocerebellar Ataxia Type 12 (SCA 12) patients

AK. Srivastava, A. Takkar, V. Goyal, F. Mohammad, R. Rajan, A. Garg (New Delhi, India)
Clinico-pathological Findings In Autopsy Cases With Non-Specific Glial Tauopathy

E. Zamrini, CH. Adler, GE. Serrano, N. Zhang, DR. Shprecher, SH. Mehta, MN. Sabbagh, E. Driver-Dunckley, HA. Shill, LI. Sue, TG. Beach (Sun City, AZ, USA)
Clinicopathologic Characterization and Abnormal Autophagy of HDLS

W. Tian, L. Cao, S. Chen (Shanghai, China)
Clinimetric properties of direct contemporaneous FOG score rating

K. Ziegler, AO. Ceballos-Baumann, UM. Fietzek (Munich, Germany)
Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome

S. Raju, K. Vyas (Bangalore, India)
Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study

X. Kang, A. Ploner, J. Ludvigsson, D. Williams, N. Pedersen, K. Wirdefeldt (Solna, Sweden)
Co-administration of levodopa and zonisamide reduces the serotonin transporter expression in a rat model of Parkinson’s disease

R. Tohge, S. Kaneko, S. Morise, M. Oki, M. Nakamura, N. Takenouchi, H. Kusaka (Hirakata, Japan)
Cockayne Syndrome manifesting as late adult onset cerebellar ataxia: expanding the phenotype

R. Chuang (Seattle, WA, USA)
Cognition and Gait in Parkinson’s Disease

A. Fatima (Lahore, Pakistan)
Cognitive ability characterization of rat model with mutated alpha-synuclein overexpression

C. Laloux, C. Lachaud, K. Timmerman, E. Bezard, R. Bordet, D. Devos (Lille, France)
Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)
Cognitive changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: A longitudinal study.

J. Mana, F. Růžička, A. Fečíková, E. Růžička, D. Urgošík, R. Jech, O. Bezdicek (Prague, Czech Republic)
Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?

R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)
Cognitive dysfunction can predict the body weight loss in patients with Parkinson’s disease

RW. Ou, QQ. Wei, YB. Hou, XQ. Yuan, HF. Shang (Chengdu, China)
Cognitive dysfunction in patients with Parkinson’s disease and psychosis

A. Lenka, S. Hegde, S. Arumugham, R. Yadav, P. Pal (Washington, DC, USA)
Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease

N. Koshel, S. Kryzhanovskyi, N. Karasevych, A. Pisaruk, I. Karaban (Kyiv, Ukraine)
Cognitive impairment in Parkinson’s Disease: A cross-sectional association study

A. Simon, C. Rodriguez-Blazquez, MJ. Forjaz, P. Martinez-Martin (Madrid, Spain)
Cognitive impairment in patients with Parkinson’s Disease

E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)
Cognitive impairment in patients with Parkinson’s syndrome

SH. Rakhimova, I. Usmonaliev, Y. Musaeva (Tashkent, Uzbekistan)
Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease

A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante (Mexico City, Mexico)
Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)
Cognitive multi-domain assessment in Parkinson’s disease: A more sensitive approach

C. Trujillo, S. Baez, E. Herrera, A. Garcia, A. Ibañez, J. Cardona (Santiago de Cali, Colombia)
Cognitive outcomes of STN-DBS in GBA mutation carriers with PD

G. Pal, E. Hill, T. Foltynie, V. Lythe, R. Alcalay, P. Garcia, K. Marder, R. Saunders-Pullman, S. Bressman, J. Aasly, B. Ouyang, Y. Liu, S. Anderson, B. Bernard, L. Verhagen (Chicago, IL, USA)
Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)
Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings

A. Petit, A. Lackmy, R. Edragas, S. Belson, A. Mongis-Marlin, C. Stattner, F. Triboulet, G. Lepage, B. Tressieres, B. Gaymard, A. Lannuzel (Fort de France, Martinique)
Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation

E. Barbosa, J. Santos, H. Fichman (Rio de Janeiro, Brazil)
Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil

N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)
Combination Antiretroviral therapy (cART)-induced cerebellar and prefrontal cortex disorders: A Study on the impact of Naringenin and Quercetin

E. Akang, O. Dosumu, A. Fagaroye, I. Usman, A. Oremosu, A. Akanmu (Lagos, Nigeria)
Combined Botulinum Toxin and Gpi DBS therapy in intractable cervical dystonia

AM. Macerollo, BH. Hammersley, ME. Esposito, JS. Somerset, RE. Ellis, MB. Bonello, JP. Panicker, DD. Damodoran, JOF. Farah, PE. Eldridge, SA. Alusi (Naples, Italy)
Combined STN and NBM DBS in PD and mild to moderate Parkinson’s dementia

R. Nickl, P. Fricke, P. Capetian, M. Reich, J. Krapp, V. Sturm, J. Volkmann, C. Matthies (Wuerzburg, Germany)
Communication Calendar for Interdisciplinary Therapy of Parkinson’s Disease

F. Adib Saberi, D. Dressler (Hamburg, Germany)
Community Home Care Nurses Training for Parkinson Disease

ST. Chua, LW. Li, HL. Ng, LT. Tan (Novena, Singapore)
Comorbid Parkinson’s disease and Myasthenia Gravis: A Case-Control Study

K. Lafaver, D. Mohanty, C. Bodkin, M. Brown, A. Druker, J. Farmer, J. Fleisher, I. Gambhir, T. Harlow, F. Leon-Sarmiento, C. Perry, Z. Wang, A. Espay (Louisville, KY, USA)
Comorbid Parkinson’s disease in a Korean patient with Alexander’s disease

KY. Kwon, JW. Cho, JK. Park (Seoul, Republic of Korea)
Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database

L. Ishihara, E. Wild, D. Oliveri (Welwyn Garden City, United Kingdom)
Comparative Grey and White Matter Tau Pathology in LBD and PSP using Digital Histologic Measurements

D. Coughlin, C. Petersen, R. Lobrovich, D. Wolk, A. Siderowf, D. Weintraub, E. Lee, J. Trojanowski, M. Grossman, D. Irwin (Philadelphia, PA, USA)
Comparative Study of Dry Needling under Ultrasound Guidance and Extracorporeal Shock Wave Therapy for Myofascial Pain and Spasticity Management

R. Bubnov, L. Kalika (Kyiv, Ukraine)
Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies

D. Hansen, T. Lashley, J. Holton, T. Warner (London, United Kingdom)
Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)
Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)

A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)
Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT

J. Gonzalez (Lima, Peru)
Comparison of Current DBS Platforms in the United States

L. Surillo, U. Yazdani, S. Chitnis (Dallas, TX, USA)
Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis

A. Shim, B. Skoog, V. Abler, N. Rashid, R. Halpern, E. Koep, M. Frazer (San Diego, CA, USA)
Comparison of Gene Expression in Parkinson’s Disease and Bipolar Disorder

FV. Delos Reyes (Quezon City, Philippines)
Comparison of high versus low frequency subthalamic stimulation on eye movement

MG. Ghilardi, L. Stock, C. Kruger-Zechlin, Z. Deeb, E. Fonoff, L. Timmermann, J. Waldthaler (Sao Paulo, Brazil)
Comparison of LFP-physiomarkers for DBS programming

G. Wenzel, S. Ewert, A. Horn, B. van Wijk, A. Kühn (Berlin, Germany)
Comparison of motor and non-motor symptoms in operated and medically treated dystonia patients

A. Maurer, U. Hidding, W. Hamel, C. Moll, C. Gerloff, M. Gelderblom, S. Zittel-Dirks (Hamburg, Germany)
Comparison of motor, non motor symptoms, impulse control disorders and quality of life in patients with young versus late onset Parkinson’s disease

S. Meka, R. Kandadai, T. Syed, R. Borgohain (Hyderabad, India)
Comparison of PDE10A and DAT expression as markers of disease burden in early Parkinson’s disease

G. Pagano, H. Wilson, T. Yousaf, F. Niccolini, N. Khan, D. Martino, R. Gunn, E. Rabiner, P. Piccini, T. Foltynie, M. Politis (London, United Kingdom)
Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms

H. Iwaki, M. Tagawa, K. Iwasaki, K. Kawakami, M. Nomoto (Toon, Japan)
Compensatory Amygdala Activity during motor timing and selection in PD

SPD. Allahdadian, H. Rafipoor, E. Yargholi, M. Mirian, MJM. Mckeown (Vancouver, BC, Canada)
Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways

JJ. Hu, T. Wang (Wuhan, China)
Complex disease burden in Parkinson’s and Advance Care Planning

M. Khwaja, A. Chatterjee, G. Alg, A. Cotton, L. Richardson, H. Avery (Reading, United Kingdom)
Complex Training of Balance in Parkinson’s Disease

ANN. Istomina, IR. Milyukhina (Saint-Petersburg, Russian Federation)
Composite UHDRS shows extensive spatial correlation with grey matter and white matter volume in Huntington’s disease gene carriers

C. Estevez-Fraga, E. Johnson, F. Rodrigues, P. Zeun, A. Durr, D. Langbehn, B. Leavitt, R. Roos, S. Gregory, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)
Comprehensive clinico-pathophysiological assessment of constipation in Parkinson’s disease

E. de Pablo-Fernandez, V. Passananti, N. Zárate-López, A. Emmanuel, T. Warner (London, United Kingdom)
Compression Therapy: A Treatment of Rubral Tremor

D. Nacopoulos (Erie, PA, USA)
Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden

F. Waga, I. Liepelt-Scarfone, M. Bentele, W. Maetzler, S. Becker, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, M. Hobert, J. Streffer, D. Berg (Titusville, NJ, USA)
Computing algorithms can detect bradykinesia from smartphone videos

S. Williams, H. Fang, D. Wong, S. Relton, C. Graham, J. Alty (Leeds, United Kingdom)
Concentration of short chain fatty acids in the peripheral blood of patients with Parkinson disease

C. Shin, Y. Lim, TB. Ahn (Seoul, Republic of Korea)
Concomitant brain pathologies have no major impact on clinical milestones in progressive supranuclear palsy

M. Jecmenica-Lukic, C. Kurz, G. Respondek, O. Grau-Rivera, Y. Compta, E. Gelpi, C. Troakes, J. van Swieten, A. Giese, S. Roeber, T. Arzberger, G. Höglinger (Munich, Germany)
Connectivity alterations in dopaminergic and cholinergic networks mediate cognitive performance in patients with Parkinson’s disease: a resting-state fMRI study

ER. de Natale, SP. Caminiti, Z. Chappell, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)
Considerations before initiating therapy in Parkinsonism: basing on the health-related quality of life.

FT. Liu, J. Wang (Shanghai, China)
Constipation with selected prodromal features increases risk of subsequent Parkinson’s Disease

E. Brown, S. Goldman, K. Albers, S. Vanden Eeden, C. Tanner (San Francisco, CA, USA)
Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

KR. Chaudhuri, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, A. Schrag, P. Martinez-Martin (London, United Kingdom)
Continuous circadian intracerebroventricular administration of anaerobic dopamine: A new therapeutic concept for Parkinson’s disease?

C. Moreau, C. Laloux, C. Lachaud, E. Pioli, Q. Li, P. Pascal, L. Defebvre, R. Bordet, E. Bezard, M. Fisichella, D. Devos (Lille, France)
Continuous dopaminergic treatment with levodopa/carbidopa intestinal gel in multiple system atrophy: report of three patients

S. Delalic, S. Ibrulj, N. Zupancic, D. Flisar, M. Trost, Z. Pirtosek, M. Kojovic (Ljubljana, Slovenia)
Continuous levodopa- carbidopa gel recovers motor cortex plasticity in advanced Parkinson’s disease

K. Kolmancic, N. Prezelj, N. Kriznar Zupancic, M. Trost, D. Flisar, M. Gregoric Kramberger, R. Rajnar, Z. Pirtosek, M. Kojovic (Ljubljana, Slovenia)
Contribution of pedunculopontine nucleus cholinergic neurons to L-DOPA-induced dyskinesia and PD motor deficits in hemi-parkinsonian rats

N. Chambers, J. Sergio, C. Saito, K. Lanza, C. Bishop (Binghamton, NY, USA)
Controlling levodopa and deep brain stimulation induced dystonia with interleaving and fractionalized current steering

A. Mammis, E. Feinstein (Newark, NJ, USA)
Convalescent Chorea in West Nile Virus Encephalitis

A. Kirby, M. Afshari (Chicago, IL, USA)
Corneal confocal microscopy: An imaging biomarker of neurodegeneration in Parkinson’s disease

M. Silverdale, I. Petropoulos, A. Kalteniece, R. Malik, C. Kobylecki, M. Ferdousi, S. Lim (Salford, United Kingdom)
Correlating subcortical structure and function in idiopathic Parkinson’s disease: A cross-sectional morphometric and [18F]-DOPA PET study

M. Rolinski, V. Sossi, A. Stoessl, C. Marshall, S. Gill, P. Clatworthy, A. Whone (Bristol, United Kingdom)
Correlation between degree of dysarthria, motor severity and quality of life in patients with Parkinson’s disease

M. Olchik, C. Rieder, L. Scudeiro, R. Rech, R. Millette, A. Ayres (Porto Alegre, Brazil)
Correlation Between Drooling and Quality of Life in Parkinson’s Disease

O. Criciotoiu, D. Stanca, R. Latea, L. Giurgiulescu, A. Mita, V. Gheorman, D. Gheonea (Craiova, Romania)
Correlation between Pareidolia and cerebral perfusion by SPECT in Parkinson’s disease without dementia: A retrospective study

H. Akamine, T. Tokashiki (Ginowan, Japan)
Correlation Between PDQ-39 and MDS-UPDRS Scores in a Phase 3 Randomized Controlled Trial of Patients with Parkinson’s Disease

T. Lokhandwala, A. Lee, B. Yue, A. Thach, B. Navia (Palm Harbor, FL, USA)
Correlation between striatal CIT uptake and Mini-Mental State Examination in Parkinson’s disease

OD. Kwon, SG. Park, SB. Lee, JA. Park (Daegu, Republic of Korea)
Correlation between structural neuroimaging and clinical outcomes in a small sample of patients with early Huntington’s disease

C. Estevez Fraga, E. Johnson, F. Rodrigues, P. Zeun, N. Hobbs, E. Rees, R. Roos, B. Landwehrmeyer, A. Durr, S. Gregory, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)
Correlation between substantia nigra measurement and UPDRS

N. Mohammadzade, F. Omrani, A. Habibi (Tehran, Islamic Republic of Iran)
Correlation of local field potentials (LFPs) to electromyography (EMG) of the rostral zona incerta (rZI) and subthalamic nucleus (STN) in Parkinson’s Disease (PD)

D. Kern, L. Kahn, S. Ojemann, A. Abosch, J. Thompson (Aurora, CO, USA)
Correlation of P300 parameters with cognition and impulse control disorders in patients with idiopathic Parkinson’s disease

R. Kandadai, R. Annakula, S. Sarva, S. Meka, T. Syed, S. Tandra, S. Turaga, R. Borgohain (Hyderabad, India)
Correlation of Retinal Nerve Fiber Layer Thickness and X-Linked Dystonia Parkinsonism Measured by Spectral-Domain Optical Coherence Tomography

MA. de Guzman, F. Levina, C. Go, E. Palisoc (Manila, Philippines)
Correlations between genetics and cortical dysfunction of paroxysmal kinesgenic dyskinesia

Y. Liu, Y. Chen, Y. Wu (Taipei, Taiwan)
Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study

N. Holland, S. Jones, J. Woodside, E. Jabbari, V. Chelban, A. Costantini, PN. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, H. Morris, J. Rowe (Cambridge, United Kingdom)
Cortical cholinergic dysfunction correlates with microglial activation in the Substantia Innominata in patients with REM sleep behavior disorder

K. Stær, A. Iranzo, M. Stokholm, K. østergaard, M. Eroles, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, P. Borghammer, D. Brooks, E. Tolosa, N. Pavese (Aarhus N, Denmark)
Cortical excitability in focal dystonia patients using threshold tracking technique

FCF. Chang, S. Kim, P. Menon, N. Geevasinga, N. Mahant, S. Babu, S. Vucic, V. Fung (Westmead, Australia)
Cortical FDG-PET patterns predict long-term motor progression and disability milestones in Parkinson’s disease

A. Pilotto, A. Imarisio, E. Premi, SP. Caminiti, L. Presotto, A. Sala, R. Turrone, R. Grasso, A. Alberici, B. Paghera, MC. Rizzetti, B. Borroni, D. Perani, A. Padovani (Brescia, Italy)
Cortical gamma oscillations as biomarkers for levodopa-induced dyskinesia

C. Güttler, J. Altschüler, K. Tanev, S. Böckmann, JK. Haumesser, A. Kühn, C. van Riesen (Berlin, Germany)
Cortical Homeostatic Plasticity Alteration in Cervical Dystonia

S. Caverzasio, N. Amato, G. Bramati, G. Koch, A. Kaelin-Lang, S. Galati (Lugano, Switzerland)
Cortical thickness analysis in Parkinson’s disease with urinary symptoms

R. Roh, K. Kim, K. Koh (Seoul, Republic of Korea)
Cough sensitivity and aspiration pneumonia in Parkinson’s disease

S. Tomita, T. Oeda, S. Takaya, M. Kohsaka, K. Park, A. Umemura, Y. Mori, T. Ishihara, S. Nomoto, M. Tahara, K. Yamamoto, H. Sawada (Kyoto, Japan)
Could we optimize the stimulation parameters setting of directional leads with a patient-specific imaging software in implanted parkinsonian patients?

AS. Rolland, N. Carriere, G. Touzet, L. Defebvre, N. Reyns, D. Devos, C. Moreau (Lille Cedex, France)
Creutzfeld Jacob disease presenting with functional-appearing, bizarre movements without significant cognitive impairment

M. Mcgraw, Z. Grujic, P. Vittal, J. Pallone (Winfield, IL, USA)
Creutzfeldt-Jakob disease with a M232R substitution (CJD232) masquerading as parkinson look-alike syndrome

KO. Jung, H. Kim, JH. Park (Bucheon-Si, Republic of Korea)
CSF levels of NFL (neurofilament light chain) in Parkinsons’ disease patients

E. Papuć, K. Rejdak (Lublin, Poland)
Cultural bias in performance of motor tasks? Comparison between Japanese and German healthy adults

K. Otte, M. Suzuki, H. Röhling, R. Kuroiwa, S. Mansow-Model, M. Mori, H. Zimmermann, AU. Brandt, F. Paul, S. Hirano, S. Kuwabara, T. Schmitz-Hübsch (Berlin, Germany)
CXCL12 is involved in α-synuclein-triggered neuroinﬂammation of Parkinson’s disease

Y. Li, M. Niu, J. Liu (Shanghai, China)